| Not Yet Recruiting | Limited Target Volume Radiotherapy After Glioblastoma Surgery Glioblastoma (GBM) | N/A | 2026-01-01 |
| Active Not Recruiting | The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma PTC, I-131, Trop2 | — | 2025-12-18 |
| Recruiting | Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasophary Nasopharyngeal Carcinoma (NPC), Recurrent Nasopharyngeal Neoplasms | Phase 2 | 2025-10-10 |
| Active Not Recruiting | Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma Nasopharyngeal Cancinoma (NPC) | — | 2025-01-01 |
| Recruiting | Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma (NPC) | Phase 2 | 2025-01-01 |
| Enrolling By Invitation | Prognostic Value of TIL in Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma (NPC) | — | 2025-01-01 |
| Active Not Recruiting | Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma Histopathological Diagnosis of Nasopharyngeal Carcinoma, Patients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition | — | 2025-01-01 |
| Recruiting | Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC Nasopharyngeal Carcinoma, Quality of Life, Thyroid Diseases | Phase 3 | 2025-01-01 |
| Recruiting | Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Ca Nasopharyngeal Carcinoma, High-Risk Cancer, Maintenance Therapy | Phase 3 | 2024-03-07 |
| Recruiting | Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-r Nasopharyngeal Carcinoma | Phase 2 | 2024-02-10 |
| Recruiting | The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC Nasopharyngeal Carcinoma, Pathologic Complete Response, Tumor Microenvironment | — | 2024-01-01 |
| Unknown | Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis Nasopharyngeal Carcinoma, Radiation-induced Oral Mucositis, Bacterial Colonization | Phase 3 | 2023-07-01 |
| Unknown | High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor Metastatic Cancer | N/A | 2023-03-01 |
| Recruiting | Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patient Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Esophageal Diseases | Phase 2 | 2022-06-02 |
| Unknown | A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases HER2-positive Metastatic Breast Cancer | Phase 2 | 2022-03-01 |
| Recruiting | Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carc Oligometastatic Disease | Phase 2 | 2021-12-01 |
| Unknown | Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer Liver Cancer | N/A | 2021-11-19 |
| Unknown | Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-sma Non-small Cell Lung Cancer | N/A | 2021-10-19 |
| Unknown | Thalidomide With or Without Probiotics in Radioactive Oral Mucositis Oral Mucositis, Quality of Life | N/A | 2021-09-20 |
| Unknown | Oral Probiotics on Radiation Enteritis Stage Ⅱ Induced by Pelvic Concurrent Chemoradiotherapy Pelvic Cancer, Enteritis, Probiotics,Chemoradiotherapy | N/A | 2021-08-27 |
| Unknown | Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carc Nasopharyngeal Carcinoma | Phase 2 | 2021-07-28 |
| Unknown | Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC Nasopharyngeal Carcinoma | Phase 3 | 2020-12-30 |
| Recruiting | A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative B Triple-Negative Breast Cancer | Phase 1 / Phase 2 | 2020-07-14 |
| Unknown | Pathological Classification of Pulmonary Nodules in Images Using Deep Learning Lung Cancer, Artificial Intelligence | — | 2020-06-01 |
| Unknown | 3D Printed Bolus in Post-mastectomy Radiotherapy Breast Neoplasms, Radiotherapy Side Effect | N/A | 2020-03-01 |
| Completed | PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Ef HCC - Hepatocellular Carcinoma, 125I Seeds Implantation | N/A | 2020-01-01 |
| Recruiting | The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Hypothyroidism | N/A | 2019-01-01 |
| Completed | Clinical Efficacy of 125I Brachytherapy Combined With Anlotinib in Radioiodine Refractory Thyroid Carcinoma Pa Thyroid Neoplasms | — | 2019-01-01 |
| Completed | Clinical Study of Pretreatment PET/CT Parameters for Predicting the Efficacy of 125I Seed Implantation in the Malignant Tumors | — | 2019-01-01 |
| Unknown | Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal Injury; Temporal Region | N/A | 2018-06-10 |
| Unknown | Effect of Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules on Oral Mucositis in Nasophary Oral Mucositis, Quality of Life | N/A | 2017-03-10 |
| Completed | Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer Thyroid Neoplasms | — | 2015-01-01 |